Biohaven Pharmaceutical
BHVN
#3116
Rank
A$6.30 B
Marketcap
$62.38
Share price
3.83%
Change (1 day)
-15.09%
Change (1 year)

Earnings for Biohaven Pharmaceutical (BHVN)

Earnings in 2024 (TTM): -A$1.27 Billion

According to Biohaven Pharmaceutical 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$0.7 Billion, an increase over its 2022 earnings that were of -A$0.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Biohaven Pharmaceutical from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$1.27 Billion81.24%
2023 -A$0.7 Billion-23.22%
2022 -A$0.91 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.22 Billion-84.13%๐Ÿ‡บ๐Ÿ‡ธ USA